Sign in Pull a receipt

SLGL

Sol-Gel Technologies Ltd.

Healthcare · Biotechnology

$246.49 sample

-1.71 (-0.69%) 1D

Market cap

$1.17T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$246.49 +1.26% 3M daily closessample

253.53229.21

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SECForm 144 filed
Oct 22INSInsider buy: Chief Executive Officer
Oct 15INSInsider sell: Chief Executive Officer
Oct 09INSInsider sell: Chief Executive Officer
Oct 06INSInsider buy: Chief Financial Officer
Sep 29INSInsider sell: Director
Sep 21INSInsider buy: Chief Executive Officer
Sep 16INSInsider sell: 10% owner

Sign up to see the real SLGL record →

Company facts

SEC EDGAR registration

Name: Sol-Gel Technologies Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in SLGL

sample

Insiders: 10 insider transactions over 90 days, net selling, $73.5M
Congress: No member trades over 90 days
Institutions · 13F: 37 funds hold $12.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$38.0B +14.8% y/y

Q4 2024Q3 2026

Inventory$23.4B +19.2% y/y

Q4 2024Q3 2026

Accounts receivable$16.4B +7.6% y/y

Q4 2024Q3 2026

Total debt$43.5B +12.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $679.4B +13.3% 3M
Sample peer B: $941.2B +12.2% 3M
Sample peer C: $550.7B -9.3% 3M
Sample peer D: $1.01T +6.4% 3M
Sample peer E: $895.1B +8.5% 3M